Medicare Access and CHIP Reauthorization Act of 2015

Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of

Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of

COVID-19 issues related to COVID-19 health care legislative and regulatory implementation and funding issues, including inpatient rehab hospitals (IRFs), Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748), Consolidated Appropriations Act, 2021 (H.R. 133).; Unified post-acute care payment system; Medicare Advantage and Prior Authorization including H.R.3107; Site neutral payment issues; Medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); Implementation of IMPACT Act of 2014 (P.L. 113-185); Implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; Value based purchasing issues, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; Preserving Rehabilitation Innovation Centers Act (H.R.1901/S.594); Improving Seniors Timely Access to Care Act (H.R.3107); The BETTER Act (H.R.3417); The Resetting The Impact Act (TRIA) (H.R. 8826); Implementation of the Continuing Care Hospital.

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office

COVID-19 health care legislative and regulatory implementation and funding issues, including issues related to inpatient rehab hospitals (IRFs), Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748), Consolidated Appropriations Act, 2021 (H.R. 133); Unified post-acute care payment system; Medicare Advantage and Prior Authorization including H.R.3107; Site neutral payment issues; Medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); Implementation of IMPACT Act of 2014 (P.L. 113-185); Implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; Value based purchasing issues, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; Preserving Rehabilitation Innovation Centers Act (H.R.1901/S.594); Improving Seniors Timely Access to Care Act (H.R.3107; The BETTER Act (H.R.3417); The Resetting The Impact Act (TRIA) (H.R. 8826); implementation of the Continuing Care Hospital.

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office

Unified post-acute care payment system; Prior Authorization including H.R.3107; Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; value based purchasing issues, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; Preserving Rehabilitation Innovation Centers Act (H.R.1901/S.594); Improving Seniors Timely Access to Care Act (H.R.3107); 3-hour rule issues and other Medicare regulatory relief

Client expense: $150,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

CARES Act; COVID-19 Provider Relief funds appropriations; IMPACT Act Reset legislation; Unified post-acute care payment system; Prior Authorization including H.R.3107; Site neutral payment issues; implementation of the Continuing Care Hospital provision in the ACA; medical necessity to post-acute care reform; The Preserving Rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; value based purchasing issues, Recovery Audit Contractor issues, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; 3-hour rule issues and other Medicare regulatory relief

Client expense: $150,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

HR 913, Clinical Treatment Act Local Coverage Determinations Clarification Act Oppose restrictive prior authorization practices. S.2425-Patient Access and Medicare Protection Act (PAMPA) implementation. Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law. for radiation therapy services; Promoting Integrity in Medicare Act (H.R. 2143) Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare. sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Implementation of H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support for reforms to the CMMI Proposed Radiation Oncology Alternative Payment Model S.3230 - TA SUPPORT Act to ensure that small and rural physician practices participating in Medicares new Merit-Based Incentive Payment System (MIPS) have access to the technical assistance. Support for waiving budget neutrality adjustments associated with evaluation and management code changes.

Client expense: $148,483 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE

COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6074),the CARES Act (S. 3548/H.R. 748); and the HEROES Act (H.R. 6800); Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)

Client expense: $230,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of

COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748);and the Heroes Act (H.R.6800) Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)

Client expense: $230,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of

Healthcare Price Transparency Rules for Hospitals 340B Medicare DSH Medicare Physician Payment (MACRA) H.R. 365 The Primary Care Enhancement Act S. 898/H.R. 2141 Conrad State 30 and Physician Access Reauthorization Act S. 1130 Rural Emergency Acute Care Hospital (REACH) Act S. 257 / H.R. 1611: Protecting Access to Rural Therapy Services Act S. 258 / H.R. 169: Critical Access Hospital Relief Act of 2015 H.R. 672 / S. 607: Rural Community Hospital Demonstration Extension Act of 2015 S. 1135: Hospital Payment Fairness Act H.R. 1479: Repeal of the Obamacare Bay State Boondoggle Act S. 1648: Rural Emergency Acute Care Hospital Act H.R. 3225: Save Rural Hospitals Act H.R. 1343 / S. 688: Establishing Beneficiary Equity in the Hospital Readmission Program Act S. 1148 / H.R. 2124: Resident Physician Shortage Reduction Act S. 2484 / H.R. 4442: CONNECT for Health Act H.R. 2156: Medicare Audit Improvement Act H.R. 5164: Rural Hospital Regulatory Relief Act S. 3435: Craig Thomas Rural Hospital and Provider Equity Act of 2016 H.R. 5406: Helping Ensure Accountability, Leadership, and Trust in Tribal Healthcare Act H.R. 34: 21st Century Cures Act H.R. 3298: Medicare Post-Acute Care Value-Based Purchasing Act H.R 1628: American Health Care Act S. 872 / H.R. 1955: Rural Hospital Access Act S. 377: Medicare Ambulance Access, Fraud Prevention and Reform Act H.R. 1156: Patient Access to Higher Quality Health Care Act of 2017 H.R. 2: Medicare Access and CHIP Reauthorization Act of 2016 H.R. 1628 Better Care Reconciliation Act (BCRA) H.R. 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes. The Senate Committee on Health, Education, Labor and Pensions (HELP) June 26 passed the Lower Health Care Costs Act of 2019 (S.1895) Congress should act now to delay the Medicaid DSH cuts that are scheduled to go into effect Nov. 22. The Coronavirus Aid, Relief, and Economic Security (CARES) Act.

Client expense: Not reported · Firm income: Not reported

CARES Act; COVID-19 Provider Relief funds appropriations; Unified post-acute care payment system; Prior Authorization including H.R.3107; Site neutral payment issues; implementation of the Continuing Care Hospital provision in the ACA; medical necessity to post-acute care reform; The Preserving Rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; value based purchasing issues, Recovery Audit Contractor issues, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; 3-hour rule issues and other Medicare regulatory relief

Client expense: $210,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Unified post-acute care payment system; Prior Authorization including H.R.3107; Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; value based purchasing issues, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; Preserving Rehabilitation Innovation Centers Act (H.R.1901/S.594); Improving Seniors Timely Access to Care Act (H.R.3107); 3-hour rule issues and other Medicare regulatory relief

Client expense: $210,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748); and the HEROES Act (H.R. 6800)Technology research.

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of

COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748); the HEROES Act (H.R. 6800)

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of

COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6704), the CARES Act (S. 3548/H.R. 748);and the Heroes Act (H.R.6800) Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254),

Client expense: $220,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE

COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6704),the CARES Act (S. 3548/H.R. 748); and the HEROES Act (H.R. 6800); Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)

Client expense: $220,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE

COVID-19 issues related to inpatient rehab hospitals (IRFs) including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Unified post-acute care payment system; Medicare Advantage and Prior Authorization including H.R.3107; Site neutral payment issues; Medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); Implementation of IMPACT Act of 2014 (P.L. 113-185); Implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; Value based purchasing issues, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; Preserving Rehabilitation Innovation Centers Act (H.R.1901/S.594); Improving Seniors Timely Access to Care Act (H.R.3107; The BETTER Act (H.R.3417); implementation of the Continuing Care Hospital.

Client expense: Not reported · Firm income: $150,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office

COVID-19 issues related to inpatient rehab hospitals (IRFs) including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Unified post-acute care payment system; Medicare Advantage and Prior Authorization including H.R.3107; Site neutral payment issues; Medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); Implementation of IMPACT Act of 2014 (P.L. 113-185); Implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; Value based purchasing issues, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; Preserving Rehabilitation Innovation Centers Act (H.R.1901/S.594); Improving Seniors Timely Access to Care Act (H.R.3107; The BETTER Act (H.R.3417); Implementation of the Continuing Care Hospital.

Client expense: Not reported · Firm income: $150,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office

HR 913, Clinical Treatment Act Local Coverage Determinations Clarification Act Oppose restrictive prior authorization practices. S.2425-Patient Access and Medicare Protection Act (PAMPA) implementation. Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law. for radiation therapy services; Promoting Integrity in Medicare Act (H.R. 2143) Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare. sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Implementation of H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support for reforms to the CMMI Proposed Radiation Oncology Alternative Payment Model S.3230 - TA SUPPORT Act to ensure that small and rural physician practices participating in Medicares new Merit-Based Incentive Payment System (MIPS) have access to the technical assistance. Support for waiving budget neutrality adjustments associated with evaluation and management code changes.

Client expense: $71,882 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE

HR 913, Clinical Treatment Act Local Coverage Determinations Clarification Act Oppose restrictive prior authorization practices. S.2425-Patient Access and Medicare Protection Act (PAMPA) implementation. Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law. for radiation therapy services; Promoting Integrity in Medicare Act (H.R. 2143) Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare. sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Implementation of H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support for reforms to the CMMI Proposed Radiation Oncology Alternative Payment Model S.3230 - TA SUPPORT Act to ensure that small and rural physician practices participating in Medicares new Merit-Based Incentive Payment System (MIPS) have access to the technical assistance. Support for waiving budget neutrality adjustments associated with evaluation and management code changes.

Client expense: $109,309 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE

Healthcare Price Transparency Rules for Hospitals 340B Medicare DSH Medicare Physician Payment (MACRA) H.R. 365 The Primary Care Enhancement Act S. 898/H.R. 2141 Conrad State 30 and Physician Access Reauthorization Act S. 1130 Rural Emergency Acute Care Hospital (REACH) Act S. 257 / H.R. 1611: Protecting Access to Rural Therapy Services Act S. 258 / H.R. 169: Critical Access Hospital Relief Act of 2015 H.R. 672 / S. 607: Rural Community Hospital Demonstration Extension Act of 2015 S. 1135: Hospital Payment Fairness Act H.R. 1479: Repeal of the Obamacare Bay State Boondoggle Act S. 1648: Rural Emergency Acute Care Hospital Act H.R. 3225: Save Rural Hospitals Act H.R. 1343 / S. 688: Establishing Beneficiary Equity in the Hospital Readmission Program Act S. 1148 / H.R. 2124: Resident Physician Shortage Reduction Act S. 2484 / H.R. 4442: CONNECT for Health Act H.R. 2156: Medicare Audit Improvement Act H.R. 5164: Rural Hospital Regulatory Relief Act S. 3435: Craig Thomas Rural Hospital and Provider Equity Act of 2016 H.R. 5406: Helping Ensure Accountability, Leadership, and Trust in Tribal Healthcare Act H.R. 34: 21st Century Cures Act H.R. 3298: Medicare Post-Acute Care Value-Based Purchasing Act H.R 1628: American Health Care Act S. 872 / H.R. 1955: Rural Hospital Access Act S. 377: Medicare Ambulance Access, Fraud Prevention and Reform Act H.R. 1156: Patient Access to Higher Quality Health Care Act of 2017 H.R. 2: Medicare Access and CHIP Reauthorization Act of 2016 H.R. 1628 Better Care Reconciliation Act (BCRA) H.R. 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes. The Senate Committee on Health, Education, Labor and Pensions (HELP) June 26 passed the Lower Health Care Costs Act of 2019 (S.1895) Congress should act now to delay the Medicaid DSH cuts that are scheduled to go into effect Nov. 22. The Coronavirus Aid, Relief, and Economic Security (CARES) Act.

Client expense: Not reported · Firm income: Not reported

Healthcare Price Transparency Rules for Hospitals 340B Medicare DSH Medicare Physician Payment (MACRA) H.R. 365 The Primary Care Enhancement Act S. 898/H.R. 2141 Conrad State 30 and Physician Access Reauthorization Act S. 1130 Rural Emergency Acute Care Hospital (REACH) Act S. 257 / H.R. 1611: Protecting Access to Rural Therapy Services Act S. 258 / H.R. 169: Critical Access Hospital Relief Act of 2015 H.R. 672 / S. 607: Rural Community Hospital Demonstration Extension Act of 2015 S. 1135: Hospital Payment Fairness Act H.R. 1479: Repeal of the Obamacare Bay State Boondoggle Act S. 1648: Rural Emergency Acute Care Hospital Act H.R. 3225: Save Rural Hospitals Act H.R. 1343 / S. 688: Establishing Beneficiary Equity in the Hospital Readmission Program Act S. 1148 / H.R. 2124: Resident Physician Shortage Reduction Act S. 2484 / H.R. 4442: CONNECT for Health Act H.R. 2156: Medicare Audit Improvement Act H.R. 5164: Rural Hospital Regulatory Relief Act S. 3435: Craig Thomas Rural Hospital and Provider Equity Act of 2016 H.R. 5406: Helping Ensure Accountability, Leadership, and Trust in Tribal Healthcare Act H.R. 34: 21st Century Cures Act H.R. 3298: Medicare Post-Acute Care Value-Based Purchasing Act H.R 1628: American Health Care Act S. 872 / H.R. 1955: Rural Hospital Access Act S. 377: Medicare Ambulance Access, Fraud Prevention and Reform Act H.R. 1156: Patient Access to Higher Quality Health Care Act of 2017 H.R. 2: Medicare Access and CHIP Reauthorization Act of 2016 H.R. 1628 Better Care Reconciliation Act (BCRA) H.R. 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes. The Senate Committee on Health, Education, Labor and Pensions (HELP) June 26 passed the Lower Health Care Costs Act of 2019 (S.1895) Congress should act now to delay the Medicaid DSH cuts that are scheduled to go into effect Nov. 22. The Coronavirus Aid, Relief, and Economic Security (CARES) Act.

Client expense: Not reported · Firm income: Not reported

CARES Act; COVID-19 Provider Relief funds appropriations; Unified post-acute care payment system; Prior Authorization including H.R.3107; Site neutral payment issues; implementation of the Continuing Care Hospital provision in the ACA; medical necessity to post-acute care reform; The Preserving Rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; value based purchasing issues, Recovery Audit Contractor issues, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; 3-hour rule issues and other Medicare regulatory relief

Client expense: $210,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Unified post-acute care payment system; Prior Authorization including H.R.3107; Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; value based purchasing issues, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; Preserving Rehabilitation Innovation Centers Act (H.R.1901/S.594); Improving Seniors Timely Access to Care Act (H.R.3107); 3-hour rule issues and other Medicare regulatory relief

Client expense: $210,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of

COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of

COVID-19 issues related to inpatient rehab hospitals (IRFs) including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Unified post-acute care payment system; Medicare Advantage and Prior Authorization including H.R.3107; Site neutral payment issues; Medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); Implementation of IMPACT Act of 2014 (P.L. 113-185); Implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; Value based purchasing issues, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; Preserving Rehabilitation Innovation Centers Act (H.R.1901/S.594); Improving Seniors Timely Access to Care Act (H.R.3107; The BETTER Act (H.R.3417); implementation of the Continuing Care Hospital.

Client expense: Not reported · Firm income: $150,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office

COVID-19 issues related to inpatient rehab hospitals (IRFs) including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Unified post-acute care payment system; Medicare Advantage and Prior Authorization including H.R.3107; Site neutral payment issues; Medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); Implementation of IMPACT Act of 2014 (P.L. 113-185); Implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; Value based purchasing issues, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; Preserving Rehabilitation Innovation Centers Act (H.R.1901/S.594); Improving Seniors Timely Access to Care Act (H.R.3107; The BETTER Act (H.R.3417); Implementation of the Continuing Care Hospital.

Client expense: Not reported · Firm income: $150,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office

COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6704) and the CARES Act (S. 3548/H.R. 748); Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)

Client expense: $180,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, White House Office

COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6704) and the CARES Act (S. 3548/H.R. 748); Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)

Client expense: $180,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, White House Office

HR 913, Clinical Treatment Act Local Coverage Determinations Clarification Act Oppose restrictive prior authorization practices. S.2425-Patient Access and Medicare Protection Act (PAMPA) implementation. Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law. for radiation therapy services; Promoting Integrity in Medicare Act (H.R. 2143) Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare. sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Implementation of H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support for reforms to the CMMI Proposed Radiation Oncology Alternative Payment Model S.3230 - TA SUPPORT Act to ensure that small and rural physician practices participating in Medicares new Merit-Based Incentive Payment System (MIPS) have access to the technical assistance.

Client expense: $109,309 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE

Healthcare Price Transparency Rules for Hospitals 340B Medicare DSH Medicare Physician Payment (MACRA) H.R. 365 The Primary Care Enhancement Act S. 898/H.R. 2141 Conrad State 30 and Physician Access Reauthorization Act S. 1130 Rural Emergency Acute Care Hospital (REACH) Act S. 257 / H.R. 1611: Protecting Access to Rural Therapy Services Act S. 258 / H.R. 169: Critical Access Hospital Relief Act of 2015 H.R. 672 / S. 607: Rural Community Hospital Demonstration Extension Act of 2015 S. 1135: Hospital Payment Fairness Act H.R. 1479: Repeal of the Obamacare Bay State Boondoggle Act S. 1648: Rural Emergency Acute Care Hospital Act H.R. 3225: Save Rural Hospitals Act H.R. 1343 / S. 688: Establishing Beneficiary Equity in the Hospital Readmission Program Act S. 1148 / H.R. 2124: Resident Physician Shortage Reduction Act S. 2484 / H.R. 4442: CONNECT for Health Act H.R. 2156: Medicare Audit Improvement Act H.R. 5164: Rural Hospital Regulatory Relief Act S. 3435: Craig Thomas Rural Hospital and Provider Equity Act of 2016 H.R. 5406: Helping Ensure Accountability, Leadership, and Trust in Tribal Healthcare Act H.R. 34: 21st Century Cures Act H.R. 3298: Medicare Post-Acute Care Value-Based Purchasing Act H.R 1628: American Health Care Act S. 872 / H.R. 1955: Rural Hospital Access Act S. 377: Medicare Ambulance Access, Fraud Prevention and Reform Act H.R. 1156: Patient Access to Higher Quality Health Care Act of 2017 H.R. 2: Medicare Access and CHIP Reauthorization Act of 2016 H.R. 1628 Better Care Reconciliation Act (BCRA) H.R. 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes. The Senate Committee on Health, Education, Labor and Pensions (HELP) June 26 passed the Lower Health Care Costs Act of 2019 (S.1895) Congress should act now to delay the Medicaid DSH cuts that are scheduled to go into effect Nov. 22.

Client expense: Not reported · Firm income: Not reported

CARES Act; Unified post-acute care payment system; Prior Authorization including H.R.3107; Site neutral payment issues; implementation of the Continuing Care Hospital provision in the ACA; medical necessity to post-acute care reform; The Preserving Rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; value based purchasing issues, Recovery Audit Contractor issues, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; 3-hour rule issues and other Medicare regulatory relief

Client expense: $216,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Unified post-acute care payment system; Prior Authorization including H.R.3107; Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; value based purchasing issues, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; Preserving Rehabilitation Innovation Centers Act (H.R.1901/S.594); Improving Seniors Timely Access to Care Act (H.R.3107); 3-hour rule issues and other Medicare regulatory relief

Client expense: $216,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).

Client expense: Not reported · Firm income: $130,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of

COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).

Client expense: Not reported · Firm income: $130,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of

COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6704) and the CARES Act (S. 3548/H.R. 748); Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)

Client expense: $250,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S., White House Office

COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6704) and the CARES Act (S. 3548/H.R. 748); Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)

Client expense: $250,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S., White House Office

COVID-19 issues related to inpatient rehab hospitals (IRFs) including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Unified post-acute care payment system; Medicare Advantage and Prior Authorization including H.R.3107; Site neutral payment issues; Medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); Implementation of IMPACT Act of 2014 (P.L. 113-185); Implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; Value based purchasing issues, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; Preserving Rehabilitation Innovation Centers Act (H.R.1901/S.594); Improving Seniors Timely Access to Care Act (H.R.3107; The BETTER Act (H.R.3417); implementation of the Continuing Care Hospital.

Client expense: Not reported · Firm income: $150,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office

COVID-19 issues related to inpatient rehab hospitals (IRFs) including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Unified post-acute care payment system; Medicare Advantage and Prior Authorization including H.R.3107; Site neutral payment issues; Medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); Implementation of IMPACT Act of 2014 (P.L. 113-185); Implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; Value based purchasing issues, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; Preserving Rehabilitation Innovation Centers Act (H.R.1901/S.594); Improving Seniors Timely Access to Care Act (H.R.3107; The BETTER Act (H.R.3417); Implementation of the Continuing Care Hospital.

Client expense: Not reported · Firm income: $150,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office

HR 913, Clinical Treatment Act Local Coverage Determinations Clarification Act Oppose restrictive prior authorization practices. S.2425-Patient Access and Medicare Protection Act (PAMPA) implementation. Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law. for radiation therapy services; Promoting Integrity in Medicare Act (H.R. 2143) Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare. sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Implementation of H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support for reforms to the CMMI Proposed Radiation Oncology Alternative Payment Model S.3230 - TA SUPPORT Act to ensure that small and rural physician practices participating in Medicares new Merit-Based Incentive Payment System (MIPS) have access to the technical assistance.

Client expense: $181,863 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE

Healthcare Price Transparency Rules for Hospitals 340B Medicare DSH Medicare Physician Payment (MACRA) H.R. 365 The Primary Care Enhancement Act S. 898/H.R. 2141 Conrad State 30 and Physician Access Reauthorization Act S. 1130 Rural Emergency Acute Care Hospital (REACH) Act S. 257 / H.R. 1611: Protecting Access to Rural Therapy Services Act S. 258 / H.R. 169: Critical Access Hospital Relief Act of 2015 H.R. 672 / S. 607: Rural Community Hospital Demonstration Extension Act of 2015 S. 1135: Hospital Payment Fairness Act H.R. 1479: Repeal of the Obamacare Bay State Boondoggle Act S. 1648: Rural Emergency Acute Care Hospital Act H.R. 3225: Save Rural Hospitals Act H.R. 1343 / S. 688: Establishing Beneficiary Equity in the Hospital Readmission Program Act S. 1148 / H.R. 2124: Resident Physician Shortage Reduction Act S. 2484 / H.R. 4442: CONNECT for Health Act H.R. 2156: Medicare Audit Improvement Act H.R. 5164: Rural Hospital Regulatory Relief Act S. 3435: Craig Thomas Rural Hospital and Provider Equity Act of 2016 H.R. 5406: Helping Ensure Accountability, Leadership, and Trust in Tribal Healthcare Act H.R. 34: 21st Century Cures Act H.R. 3298: Medicare Post-Acute Care Value-Based Purchasing Act H.R 1628: American Health Care Act S. 872 / H.R. 1955: Rural Hospital Access Act S. 377: Medicare Ambulance Access, Fraud Prevention and Reform Act H.R. 1156: Patient Access to Higher Quality Health Care Act of 2017 H.R. 2: Medicare Access and CHIP Reauthorization Act of 2016 H.R. 1628 Better Care Reconciliation Act (BCRA) H.R. 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes. The Senate Committee on Health, Education, Labor and Pensions (HELP) June 26 passed the Lower Health Care Costs Act of 2019 (S.1895) Congress should act now to delay the Medicaid DSH cuts that are scheduled to go into effect Nov. 22.

Client expense: Not reported · Firm income: Not reported

Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (S. 692, H.R. 2207); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling, FDA reform; Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (H.R. 2740); Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).

Client expense: Not reported · Firm income: $130,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); telemedicine and connected care; remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); Protect Medical Innovation Act of 2019 (H.R. 2207/S. 692); the implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); safe patient handling, FDA reform; Extension of Continuing Appropriations Act of 2018. Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (H.R. 2740); Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).

Client expense: Not reported · Firm income: $130,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Unified post-acute care payment system; Medicare Advantage and Prior Authorization including H.R.3107; Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; value based purchasing issues, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; Preserving Rehabilitation Innovation Centers Act (H.R.1901/S.594); Improving Seniors Timely Access to Care Act (H.R.3107; The BETTER Act (H.R.3417).

Client expense: Not reported · Firm income: $150,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office